Low molecular weight chitosan inhibits obesity induced by feeding a high-fat diet long-term in mice

Journal of Pharmacy and Pharmacology

Volumn 58, Issue 2, 2006, Pages 201-207

  Sumiyoshi, Maho ^a   Kimura, Yoshiyuki ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILE ACID; CHITOSAN; FECES LIPID; HYMECROMONE; LIPID; NITROGEN; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILIARY EXCRETION; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE MODEL; ENZYME ACTIVITY; ENZYME INHIBITION; FECES LEVEL; FOOD SAFETY; FUNCTION TEST; HYDROLYSIS; LIPID BLOOD LEVEL; LIPID DIET; LIPID LIVER LEVEL; MALE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; OBESITY; ORAL LIPID TOLERANCE TEST; ORGAN WEIGHT; SMALL INTESTINE ABSORPTION; SOLUBILITY; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; VISCOSITY; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE; ANIMALS; ANTICHOLESTEREMIC AGENTS; BUTTER; CHITOSAN; CHOLESTEROL; DIET; FECES; LIPASE; LIVER; MALE; MICE; MICE, INBRED C57BL; MOLECULAR WEIGHT; OBESITY; PANCREAS; SWINE; TRIGLYCERIDES; WEIGHT GAIN;

EID: 31544480928     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.58.2.0007     Document Type: Article

References (32)

1. Deuchi, K., Kanauchi, O., Imasato, Y., Kobayashi, E. (1995) Effect of the viscosity or deactylation degree of chitosan on faecal fat excreted from rats fed on a high-fat diet. Biosci. Biotechnol. Biochem. 59: 781-785
2. Fletcher, M. J. (1968) A colorimetric method for estimating serum triglycerides. Clin. Chim. Acta. 22: 393-397
3. Fujioka, S., Matsuzawa, Y., Tokunaga, K., Tarui, S. (1987) Contribution of intraabodominal fat accumulation to the impairment of glucose and lipid metabolism. Metabolism 36: 54-59
4. Gades, M. D., Stern, J. S. (2002) Chitosan supplementation does not affect fat absorption in healthy males fed a high-fat diet, a pilot study. Int. J. Obes. 26: 119-122
5. Gallaher, C. M., Munion, J. M., Hesslink, R. Jr, Wise, J., Gallaher, D. D. (2000) Cholesterol reduction by glucomannan and chitosan is mediated by changes in cholesterol absorption and bile acid and fat excretion in rats. J. Nutr. 130: 2753-2759
6. Gallaher, D. D., Hassel, C. A., Lee, K.-J., Gallaher, C. M. (1993) Viscosity and fermentability as attributes of dietary fiber responsible for the hypocholesterolemic effect in hamsters. J. Nutr. 123: 244-252
7. Guercioline, R., Radu-Radulescu, L., Boldrin, M., Dalla, J., Moore, R. (2001) Comparative evaluation of fecal fat excretion induced by orlistat and chitosan. Obes. Res. 9: 364-367
8. Han, L.-K., Kimura, Y., Okuda, H. (1999) Reduction in fat storage during chitin-chitosan treatment in mice fed a high-fat diet. Int. J. Obes. 23: 174-179
9. Hatanaka, M. (1996) Manufacture of water-soluble chitosan with low molecular weight. Japanese Patent No. 2547153
10. Hayashi, K., Ito, M. (2002) Antidiabetic action of low molecular weight chitosan in genetically obese diabetic KK-Ay mice. Biol. Pharm. Bull. 25: 188-192
11. Ho, S. C., Tai, E. S., Eng, P. H., Tan, C. E., Fok, A. C. (2001) In the absence of dietary surveillance, chitosan doses not reduce plasma lipids or obesity in hypercholesterolaemic obese Asian subjects. Singapore Med. J. 42: 6-10
12. Kato, H., Taguchi, T., Okuda, H., Kondo, M., Takara, M. (1994) Anti-hypertensive effects of chitosan in rats and humans. J. Trad. Med. 11: 198-205
13. Kimura, Y., Okuda, H. (1999) Prevention by chitosan of myelotoxicity, gastrointestinal toxicity and immunocompetent organic toxicity induced by 5-fluorouracil without loss of antitumor activity in mice. Jpn. J. Cancer 90: 765-774
14. Kimura, Y., Onoyama, M., Sera, T., Okuda, H. (2000) Antitumor activity and side effects of combined treatment with chitosan and cisplatin in sarcoma 180-bearing mice. J. Pharm. Pharmacol. 52: 883-890
15. Kimura, Y., Sawai, N., Okuda, H. (2001) Antitumor activity and adverse reactions of combined treatment with chitosan and doxorubicin in tumor-bearing mice. J. Pharm. Pharmcol. 53: 1373-1378
16. Lee, J. K., Kim, U. S., Kim, J. H. (1999) Modification of chitosan to improve its hypocholesterolemic capacity. Biosci. Biotechnol. Biochem. 63: 833-839
17. LeHoux, J. G., Grondin, F. (1993) Some effects of chitosan on liver function in the rat. Endocrinology 132: 1078-1084
18. Maeda, Y., Kimura, Y. (2004) Antitumor effects of various low-molecular-weight chitosans are due to increased natural killer activity of intestinal intraepithelial lymphocytes in sarcoma 180-bearing mice. J. Nutr. 134: 945-950
19. Ormrod, D. J., Holmes, C. C., Miller, T. E. (1998) Dietary chitosan inhibits hypercholesterolemia and atherogenesis in the apolipoprotein E-deficient mouse model of atherosclerosis. Atherosclerosis 138: 329-334
20. Pitter, M. H., Abbot, N. C., Harkness, E. F., Ernst, E. (1999) Randomized, double-blind trial of chitosan for body weight reduction. Eur. J. Clin. Nutr. 53: 379-381
21. Roberts, C. K., Liang, K., Barnard, R. J., Kim, C. H., Vaziri, N. D. (2004) HMG-CoA reductase, cholesterol 7α-hydroxylase, LDL receptor, SR-B1 and ACAT in diet-induced syndrome X. Kidney Int. 66: 1503-1511
22. Shon, Y.-H., Park, I.-K., Moon, I.-S., Chang, H. W., Park, I.-K., Nam, K.-S. (2002) Effect of chitosan oligosaccharide on 2,3,7,8-tetrachlorodibenzo-p- dioxin-induced oxidative stress in mice. Biol. Pharm. Bull. 25: 1161-1164
23. Singla, A. K., Chawla, M. (2001) Chitosan: some pharmaceutical and biological aspects - an update. J. Pharm. Pharmacol. 53: 1047-1067
24. Sugano, M., Fujikawa, Y., Hiratsuji, K., Nakashima, N., Fukuda, N., Hasegawa, Y. (1980) A novel use of chitosan as a hypocholesterolemic agent in rats. Am. J. Clin. Nutr. 33: 787-793
25. Sugano, M., Watanabe, S., Kishi, A., Izume, M., Ohtakara, A. (1988) Hypocholesterolemic action of chitosan with different viscosity in rats. Lipids 23: 187-191
26. Tai, T.-S., Sheu, W. H.-H., Lee, W.-J., Yao, H.-T., Chiang, M.-T. (2000) Effect of chitosan on plasma lipoprotein concentrations in type 2 diabetic subjects with hypercholesterolemia. Diabetes Care 23: 1703-1704
27. Tsujita, T., Okuda, H. (1983) Carboxylesterase in rat and human sera and their relationship to serum aryl acylamidases and cholinesterase. Eur. J. Biochem. 133: 215-220
28. Wang, P.-R., Guo, Q., Ippolito, M., Wu, M., Milot, D., Ventre, J. Doebber, T., Wright, S. D., Chao, Y.-S. (2001) High fat fed hamster, a unique animal model for treatment of diabetic dyslipidemia with peroxisome proliferate activated receptor alpha selective agonists. Eur. J. Pharmacol. 427: 285-293
29. Wuolijioki, E., Hirvela, T., Ylitalo, P. (1999) Decrease in serum LDL cholesterol with microcrystalline chitosan. Methods Find. Exp. Clin. Pharmacol. 21: 357-361
30. Yao, H. T., Chiang, M. T. (2002) Plasma lipoprotein cholesterol in rats fed a diet enriched in chitosan and cholesterol. J. Nutr. Sci. Vitaminol. 48: 379-383
31. Young, S. C., Hui, D. Y. (1999) Pancreatic lipase/colipase-mediated triacylglycerol hydrolysis is required for cholesterol transport from lipid emulsions to intestinal cells. Biochem. J. 339: 615-620
32. Zak, B., Dickman, R. C., White, E. G., Burnett, H., Cherney, P. J. (1954) Rapid estimation of free and total cholesterol. Am. J. Clin. Pathol. 24: 1307-1315